These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 26794883)

  • 1. Adjuvant Chemotherapy Improves the Probability of Freedom From Recurrence in Patients With Resected Stage IB Lung Adenocarcinoma.
    Hung JJ; Wu YC; Chou TY; Jeng WJ; Yeh YC; Hsu WH
    Ann Thorac Surg; 2016 Apr; 101(4):1346-53. PubMed ID: 26794883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Factors in Completely Resected Node-Negative Lung Adenocarcinoma of 3 cm or Smaller.
    Hung JJ; Yeh YC; Wu YC; Chou TY; Hsu WH
    J Thorac Oncol; 2017 Dec; 12(12):1824-1833. PubMed ID: 28739441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance and adjuvant chemotherapy survival benefits of a solid or micropapillary pattern in patients with resected stage IB lung adenocarcinoma.
    Qian F; Yang W; Wang R; Xu J; Wang S; Zhang Y; Jin B; Yu K; Han B
    J Thorac Cardiovasc Surg; 2018 Mar; 155(3):1227-1235.e2. PubMed ID: 29223834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic and predictive value of the novel classification of lung adenocarcinoma in patients with stage IB.
    Luo J; Huang Q; Wang R; Han B; Zhang J; Zhao H; Fang W; Luo Q; Yang J; Yang Y; Zhu L; Chen T; Cheng X; Wang Y; Zheng J; Wu H; Xia W; Chen H
    J Cancer Res Clin Oncol; 2016 Sep; 142(9):2031-40. PubMed ID: 27379889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of the international association for the study of lung cancer/American Thoracic Society/European Respiratory Society classification of lung adenocarcinoma in tumor recurrence and patient survival.
    Hung JJ; Yeh YC; Jeng WJ; Wu KJ; Huang BS; Wu YC; Chou TY; Hsu WH
    J Clin Oncol; 2014 Aug; 32(22):2357-64. PubMed ID: 24799473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of adjuvant chemotherapy on survival of patients with stage IB non-small cell lung cancer with visceral pleural invasion.
    Xie J; Zhang X; Hu S; Peng WD; Xu B; Li Y; Zhang SJ; Li Q; Li C
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2231-2239. PubMed ID: 32533405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society lung adenocarcinoma classification on death and recurrence in completely resected stage I lung adenocarcinoma.
    Hung JJ; Jeng WJ; Chou TY; Hsu WH; Wu KJ; Huang BS; Wu YC
    Ann Surg; 2013 Dec; 258(6):1079-86. PubMed ID: 23532112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a low risk subgroup of stage IB lung adenocarcinoma patients.
    Mizuno T; Ishii G; Nagai K; Yoshida J; Nishimura M; Mochizuki T; Kawai O; Hasebe T; Ochiai A
    Lung Cancer; 2008 Dec; 62(3):302-8. PubMed ID: 18486987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Lepidic Component Occupancy on Effects of Adjuvant Chemotherapy for Lung Adenocarcinoma.
    Sasada S; Miyata Y; Mimae T; Mimura T; Okada M
    Ann Thorac Surg; 2015 Dec; 100(6):2079-86. PubMed ID: 26298165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Adjuvant Chemotherapy after Complete Resection for Pathologic Stage IB Lung Adenocarcinoma in High-Risk Patients as Defined by a New Recurrence Risk Scoring Model.
    Jang HJ; Cho S; Kim K; Jheon S; Yang HC; Kim DK
    Cancer Res Treat; 2017 Oct; 49(4):898-905. PubMed ID: 28111426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Micropapillary Predominant Lung Adenocarcinoma in Stage IA Benefits from Adjuvant Chemotherapy.
    Wang C; Yang J; Lu M
    Ann Surg Oncol; 2020 Jun; 27(6):2051-2060. PubMed ID: 31848813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of adjuvant chemotherapy for lung adenocarcinoma patients with positive pleural lavage cytology findings.
    Ogawa H; Uchino K; Tanaka Y; Shimizu N; Okuda Y; Tane K; Tauchi S; Nishio W; Maniwa Y; Yoshimura M
    Interact Cardiovasc Thorac Surg; 2015 Jul; 21(1):34-9. PubMed ID: 25911680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification in stage IB lung adenocarcinoma.
    Xu CH; Wang W; Wei Y; Hu HD; Zou J; Yan J; Yu LK; Yang RS; Wang Y
    Eur J Surg Oncol; 2015 Oct; 41(10):1430-6. PubMed ID: 26123994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of adjuvant chemotherapy in stage IB non-small-cell lung cancer: an analysis of 112 consecutively treated patients.
    Dediu M; Ion O; Ion R; Alexandru A; Median D; Gal C; Horvat T; Motas C; Motas N
    J BUON; 2012; 17(2):317-22. PubMed ID: 22740212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KRAS Mutation Is a Significant Prognostic Factor in Early-stage Lung Adenocarcinoma.
    Kadota K; Sima CS; Arcila ME; Hedvat C; Kris MG; Jones DR; Adusumilli PS; Travis WD
    Am J Surg Pathol; 2016 Dec; 40(12):1579-1590. PubMed ID: 27740967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Solid Minor Histologic Subtype in Postsurgical Prognosis of Stage I Lung Adenocarcinoma.
    Chen T; Luo J; Gu H; Gu Y; Huang Q; Wang Y; Zheng J; Yang Y; Chen H
    Ann Thorac Surg; 2018 Jan; 105(1):302-308. PubMed ID: 29162222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of adjuvant chemotherapy in patients with resected stage IB solid predominant and solid non-predominant lung adenocarcinoma.
    Cao S; Teng J; Xu J; Han B; Zhong H
    Thorac Cancer; 2019 Feb; 10(2):249-255. PubMed ID: 30561142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of Lepidic Component Predominance to Adjuvant Chemotherapy with Oral Fluoropyrimidines for Stage I Lung Adenocarcinoma.
    Sasada S; Miyata Y; Mimae T; Tsutani Y; Mimura T; Okada M
    Clin Lung Cancer; 2016 Sep; 17(5):433-440.e1. PubMed ID: 26725850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic role of pathologic invasive component size, excluding lepidic growth, in stage I lung adenocarcinoma.
    Tsutani Y; Miyata Y; Mimae T; Kushitani K; Takeshima Y; Yoshimura M; Okada M
    J Thorac Cardiovasc Surg; 2013 Sep; 146(3):580-5. PubMed ID: 23778085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of adjuvant chemotherapy for non-small cell lung cancer assessed by metastatic potential associated with ACTN4.
    Miura N; Kamita M; Kakuya T; Fujiwara Y; Tsuta K; Shiraishi H; Takeshita F; Ochiya T; Shoji H; Huang W; Ohe Y; Yamada T; Honda K
    Oncotarget; 2016 May; 7(22):33165-78. PubMed ID: 27121206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.